IndiaTickerAnnual Report 2026 - AstraZeneca Pharma India Ltd.BSE · annual report · 206 pages
VerifiedArchived copy Company dossier
AstraZeneca Pharma
NSE:ASTRAZEN · ISIN INE203A01020
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
AstraZeneca Pharma
Business
Business evidence pack
Source documentsPrimary material for understanding AstraZeneca Pharma
Business-model synthesis will be generated from the company's annual reports, investor presentations and conference-call material. Until that layer is reconciled, IndiaTicker shows the source pack instead of company-specific claims.
AstraZeneca Pharma India Ltd - 506820 - Reg. 34 (1) Annual Report.BSE · annual report · 206 pages
VerifiedArchived copy Annual Report 2025 - AstraZeneca Pharma India Ltd.BSE · annual report · 203 pages
VerifiedArchived copy Financial Year 2012 from bseBSE · annual report · 92 pages
VerifiedArchived copy Financial Year 2014 from bseBSE · annual report · 50 pages
VerifiedArchived copy Financial Year 2013 from bseBSE · annual report · 101 pages
VerifiedArchived copy Financial Year 2020 from bseBSE · annual report · 137 pages
VerifiedArchived copy Financial Year 2015 from bseBSE · annual report · 117 pages
VerifiedArchived copy Financial Year 2017 from bseBSE · annual report · 144 pages
VerifiedArchived copy Financial Year 2016 from bseBSE · annual report · 120 pages
VerifiedArchived copy Financial Year 2025 from bseBSE · annual report · 203 pages
VerifiedArchived copy Financial Year 2022 from bseBSE · annual report · 73 pages
VerifiedArchived copy Financial Year 2023 from bseBSE · annual report · 80 pages
VerifiedArchived copy Financial Year 2021 from bseBSE · annual report · 119 pages
VerifiedArchived copy Financial Year 2019 from bseBSE · annual report · 117 pages
VerifiedArchived copy Financial Year 2018 from bseBSE · annual report · 92 pages
VerifiedArchived copy